Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Production / Operations Routine +

WELL Health Reports Record Canadian Patient Visits and Primary Care Margin Expansion in Q1-2026

Margin Expansion Validates Operational Leverage Amidst U.S. Asset Divestiture Uncertainty

By The Northwire Desk — AI Analysis Apr 21, 2026 · 07:01 WELL · 4.16 WELL HEALTH TECHNOLOGIES CORP. J
Executive Summary
  • WELL Health Technologies reported Q1-2026 Canadian Patient Visits of 1.27 million, a 33% year-over-year increase.
  • Primary Care Adjusted EBITDA margins expanded to approximately 8%, up from 6% in Q1-2025.
  • Affiliate Clinic network grew to 74 locations within the strategic alliance with a national retailer.
  • CardiologyNow virtual specialty-care platform saw a 65% year-to-date increase in consultation billings.
  • Total Canadian clinics reached 253 (15% YoY increase) and healthcare providers reached 3,158 (17% YoY increase).
Material Impact
  • The Q1-2026 operational update confirms the strong growth trajectory established in the FY2025 earnings release on March 19, 2026.
  • Margin expansion from 6% to 8% in Primary Care is a positive indicator of the clinic transformation program's effectiveness but aligns with management guidance expectations rather than exceeding them significantly.
  • The news serves as validation of the FY2026 revenue and EBITDA guidance ($1.55-$1.65B Revenue, $175-$185M Adjusted EBITDA) provided in March 2026.
  • As a quarterly operations update following an earnings release less than two months prior, the information is largely incremental rather than transformative.
  • The market reaction to the FY2025 results (March 19) saw a price decline from ~$4.35 to $3.77; this news provides fundamental support for a recovery but does not introduce new strategic catalysts like M&A or financing rounds seen previously in the year.
WELL · Price
Company Overview
  • Company: WELL Health Technologies Corp. operates Canada's largest outpatient healthcare network.
  • Flagship Project: The Canadian Patient Services network, comprising 253 clinics and over 3,100 providers, focusing on primary care, diagnostics, and specialty virtual care (CardiologyNow).
  • Subsidiaries: WELLSTAR Technologies (SaaS/medical billing), CYBERWELL (Cybersecurity), HEALWELL AI (AI-driven patient identification).
  • Strategic Alliance: Ten-year strategic alliance with a large national retailer for Affiliate Clinic locations.
  • Business Model: Mix of owned clinics, affiliate licensee locations, and SaaS platforms generating revenue from patient visits, billing services, and cybersecurity solutions.
Read the original news release →

More from WELL HEALTH TECHNOLOGIES CORP. J

Jun 12, 2026 · 07:02

WELL Health Provides a Corporate Update on Circle Medical

Production / Operations Jun 02, 2026 · 06:31

WELL Health Improves Guidance Based on WELL Canada Achieving $100 Million in Annualized Adjusted EBITDA Run-Rate Ahead of Schedule

M&A / Property May 19, 2026 · 07:01

WELL Health Renews Share Buyback Amidst Strong Earnings Growth and Strategic Spin-Out Plans

Other May 07, 2026 · 16:01

WELL Health Q1 Earnings Beat Revenue Targets But Cash Flow Divergence Raises Liquidity Concerns

Earnings Apr 14, 2026 · 07:30

WELL Health Technologies Corp.

Production / Operations Apr 02, 2026 · 12:29

Well Health forms partnership with AliveCor

M&A / Property